Physician-supervised injectable peptide therapy for advanced wellness protocols. In-depth research on Tesamorelin, BPC-157, TB-500, GHK-Cu, KPV, NAD+, Ipamorelin, MOTS-c, and other injectable compounds. All injectable peptides require a consultation before purchase.
KPV is a powerful anti-inflammatory tripeptide that inhibits NF-κB signaling. Research shows it reduces intestinal inflammation and modulates immune responses without immunosuppression.
GHK-Cu is a naturally occurring copper peptide that declines with age. Research shows it modulates over 30% of human genes, shifting expression toward a younger pattern.
TB-500 is a synthetic fragment of Thymosin Beta-4 that promotes cell migration, reduces inflammation, and accelerates tissue repair. Here's what the research shows.
The definitive guide to BPC-157 — over 100 studies, multiple tissue types, and decades of research. Mechanisms, clinical applications, delivery methods, and what the science actually shows.
The KLOW protocol adds KPV's powerful anti-inflammatory action to the GLOW stack. Learn how this four-peptide combination addresses inflammation and repair simultaneously.
The GLOW protocol combines three of the most researched tissue-repair peptides — BPC-157, TB-500, and GHK-Cu — into a single regenerative stack. Here's the science behind each component.
GLP-3 is an emerging area of peptide research building on the success of GLP-1 and GLP-2. Here's what the early science suggests about this next-generation peptide.
GLP-2 is a naturally occurring peptide that stimulates intestinal growth and repair. Learn about its mechanisms, clinical applications, and why it's gaining attention for gut health.